- Home
- WU vs TXG Comparison
WU vs TXG Comparison
Compare WU & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WU | TXG |
|---|---|---|
| Founded | 1851 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2006 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WU | TXG |
|---|---|---|
| Price | $9.04 | $17.41 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 14 |
| Target Price | $9.00 | ★ $17.18 |
| AVG Volume (30 Days) | ★ 8.2M | 2.2M |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 10.46% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ 1.52 | N/A |
| Revenue | ★ $4,050,700,000.00 | $245,893,000.00 |
| Revenue This Year | $8.45 | N/A |
| Revenue Next Year | $4.69 | $7.26 |
| P/E Ratio | $5.94 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $7.85 | $6.78 |
| 52 Week High | $10.77 | $23.56 |
Technical Indicators
Market Signals| Indicator | WU | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 38.15 |
| Support Level | $7.96 | $11.62 |
| Resistance Level | $9.73 | $17.33 |
| Average True Range (ATR) | 0.26 | 1.34 |
| MACD | -0.06 | -0.50 |
| Stochastic Oscillator | 1.60 | 18.38 |
Price Performance
Historical ComparisonAbout WU Western Union Company (The)
Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2025 and is the largest money transfer company in the world.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).